Compounded semaglutide vs brand name Wegovy: what is the real difference?

Short answer

• Chemically, compounded semaglutide can be the same active molecule as Wegovy. The real differences are in regulation, manufacturing quality control, device/formulation, clinical testing, and legal/insurance issues. Those differences affect safety, consistency, and how well the product matches the outcomes seen in Wegovy clinical trials.

Detailed differences (what matters to you)

• Regulatory approval and evidence

  • Wegovy (Novo Nordisk) is FDA‑approved for chronic weight management after large randomized trials showing benefits and known safety data.
  • Compounded semaglutide is not FDA‑approved as a finished product. There are no large, standardized clinical trials proving that a particular compounded product gives the same weight‑loss results or side‑effect profile.

• Manufacturing quality and testing

  • Wegovy is manufactured under strict Good Manufacturing Practices (GMP), with confirmed potency, purity, and sterility testing.
  • Compounded products are made by pharmacies to order. Quality can vary. Risks include incorrect potency, impurities/contaminants, or sterility breaches (important for injectable drugs).

• Formulation and delivery device

  • Wegovy comes in a standard, tested pen device and a specific proprietary formulation that controls stability and dose delivery.
  • Compounded semaglutide may be provided as a vial (requiring drawing doses) or in different concentrations; that increases risk of dosing errors and infection from handling.

• Stability, shelf life, and storage

  • Wegovy’s storage, expiration, and stability are defined by the manufacturer.
  • Compounded formulations may have shorter or less-certain stability and inconsistent storage instructions unless the pharmacy provides validated data.

• Safety and traceability

  • With Wegovy you have known adverse-event data, and manufacturer support/recall procedures.
  • With compounded products you may have limited traceability; if problems occur it is harder to track lots or get manufacturer support.

• Legal/regulatory/insurance aspects

  • Wegovy is an FDA‑approved brand product and more likely to be covered (or eligible for manufacturer savings) when coverage applies.
  • Compounded semaglutide may not be covered by insurance, may be against state/federal guidance if made from bulk drug substances in certain circumstances, and some prescribers/insurers discourage or prohibit substitution.

When people choose compounded semaglutide

• Common reasons: lower cash price, local availability, or needle/vial preferences.
• Tradeoffs: possible lower cost vs increased safety/quality risk and lack of proven equivalence to Wegovy.

If you’re considering compounded semaglutide — practical precautions

• Prefer an FDA‑approved product (Wegovy) when possible.
• If using a compounding pharmacy, choose one with sterile compounding accreditation and oversight:
  • Look for PCAB accreditation (Pharmacy Compounding Accreditation Board) or ACHC accreditation, and USP <797>/<800> compliance.
  • Ask the pharmacy for certificate(s) of analysis (COA) showing potency and purity from an independent lab, and for sterility testing records and expiration dating.
  • Confirm the pharmacy is licensed in your state and check the state board of pharmacy for any complaints.
• Avoid unverified online sellers or imported products of unknown origin.

Cost and access options

• Wegovy (Novo Nordisk) — manufacturer has savings programs and patient support; check Novo Nordisk’s Wegovy savings card and patient assistance resources.
• If cost or insurance is an issue, discuss alternatives with your clinician:
  • Ozempic (semaglutide — Novo Nordisk) is FDA‑approved for type 2 diabetes and commonly used off‑label for weight loss at different doses.
  • Other prescription options (different drugs/classes) may also be appropriate depending on your health profile (e.g., tirzepatide/Mounjaro — Eli Lilly).
• Also check GoodRx and speak with your insurer and the manufacturer’s patient support for possible savings or assistance.

Bottom line

• Wegovy gives standardized, FDA‑tested dosing, safety data, and manufacturer support — that’s the safer, proven choice for weight‑management semaglutide.
• Compounded semaglutide can be cheaper or tailored but carries higher risk for variable potency, contamination, dosing errors, and lack of proven equivalence. If you choose compounding, use an accredited sterile-compounding pharmacy and request COAs and sterility documentation, and discuss the choice with your prescriber.

If you want, tell me whether cost, availability, or another factor (e.g., needle type) is your main concern and I can suggest next steps (specific savings programs, how to evaluate a compounding pharmacy, or alternatives like Ozempic/Mounjaro).